23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS, CA
PharmaCyte Biotech Increases Shares in 2022 Equity Incentive Plan
Annual Report to Security Holders
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Amended material disclosure
Changes in Board, Management or Compensation, Shareholder votes
Material Contracts, Completing Asset Acquisition or Sale, Reg. FD
Announces $7 Million Capital Raise, Led by Existing Investors
Shareholder votes
Q2
Notice of Late Filing for Quarterly Report
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Amended Tender Offer Statement by Issuer